Comparative analysis of vaccine and disease induced immunity and immunological evaluation of COVID-19 vaccines on effectiveness and safety
Bidragets beskrivning
A novel coronavirus, SARS-CoV-2 started the first coronavirus pandemic in early 2020. The virus spreads mainly via respiratory droplets and occasionally the disease leads to a severe lower respiratory tract infection, acute respiratory failure and death. Globally, as of June 2020 there have been nearly 6,5 million cases and 400 000 deaths due to COVID-19 infection. Our research consortium concentrates on analyzing the activation and specificity of antibody and cell-mediated immunity in COVID-19 infected and vaccinated individuals. We intend to identify the viral targets of protective immunity and in longitudinal follow-up studies analyze the natural infection and COVID-19 vaccine-induced immunity at individual and population level. The study has a significant public health impact and the data produced by the project is likely to enhance pandemic preparedness and response as well as to direct coronavirus vaccination policy in Finland.
Visa merStartår
2020
Slutår
2022
Beviljade finansiering
Rollen i Finlands Akademis konsortium
Partner
Finansiär
Finlands Akademi
Typ av finansiering
Akademiprojekt med särskild inriktning
Övriga uppgifter
Finansieringsbeslutets nummer
336411
Vetenskapsområden
Biomedicinska vetenskaper
Forskningsområden
Biolääketieteet
Temaområden
Lisätalousarvio III 2020
Identifierade teman
covid, pandemic, vaccines